
| Heidi Lyng | |
| Position: | Scientist |
| Phone: | +47 22 78 1478 |
| Email: | |
Mobile phone: + 47 976 83 759
Mini CV
Personal Information
Date of birth: October 12th, 1960
Nationality: Norwegian
Marital status: Married, 3 children
Tel.: +47 67562708 (home), +47 22934258 (work)
E-mail: heidi.lyng@rr-research.no; Web: http://www.radium.no/lyng/
Current Position
Since January 1998 scientist at Department of Radiation Biology, Institute for Cancer Research, Norwegian Radium Hospital (NRH), Oslo, Norway.
Employments
1985 September - December, Division of Applied Chemistry, SINTEF
1986 - 1991 Doctoral fellowship, The Norwegian cancer Society
1992 - 1993 Doctoral fellowship, NRH
1994 - 1997 Post doctoral fellowship, The Norwegian Cancer Society
1998 - 2004 Scientist, The Norwegian Cancer Society
2004 - Scientist, Center for Research and Training in Radiation Therapy (SUFS), NRH
Education and Qualifications
1986 Master of Science, Biophysics and Medical Technology, Faculty of Physics and
Mathematics, The Norwegian Institute of Technology (NTH).
1993 Ph.D. in Biophysics, Faculty of Mathematics and Natural Science, University of Oslo (UiO)
2000 Evaluated and found qualified for a professor position
Research Experience
1986 M.S. student, Division of Applied Chemistry, SINTEF
Thesis: Bruk av flowcytometri ved fermetering av Saccharamyces Cerevisiae
1987-93 PhD student, Group of Tumor Physiology and Radiation Biology, Dept of Radiation
Biology, NRH
Thesis: Blood flow and thermoradiotherapy of locally advanced breast carcinoma
1994-97 Post doc, Group of Tumor Physiology and Radiation Biology, Dept of Radiation
Biology, NRH
Project: Prediction of tumor response to radiotherapy
1998-2000 Scientist, Group of Tumor Physiology and Radiation Biology, Dept of Radiation
Biology, NRH
Project leader: Vascularization and interstitial fluid pressure in tumors
2001- Scientist, Project group of Clinical Radiation Biology, Dept of Radiation Biology, NRH
Project leader: Molecular biomarkers in radiotherapy of cancer
Supervision
Students for their diploma:
1996 Gro Aanesland Dahle, Institute of Physics, NTNU
1997 Gøril Olsen, Institute of Physics, NTNU
1999 Ann Olaug Vorren and Ståle Leigland Nybakk, Institute of Physics, NTNU
2001 Tonje Holter Bay, Institute of Physics, NTNU
2003 Katrine Indregård and Bård Mathiesen, HiO
2005 Runar Søndersrød Brøvig, Institute of Physics, NTNU
2006 Eli Faksvåg Caspersen and Anne Katrine Hindhammer, Institute of Pharmacy, UiO
2008 Mojgan Mirzaei, Master degree, Institute of Pharmacy, UiO
Co-supervisor with collaborators in statistics (main supervisor):
2003 Ida Scheel, Diploma, Department of Mathematical Sciences, NTNU (with Frigessi, Glad)
2004 Rita Terese Naustdal, Project, Institute of Physics, NTNU (with Langaas)
2004 Ragnhild Sørum, Diploma, Institute of Mathematics, UiO (with Frigessi, Glad)
2007 Linn Cecilie Bergersen, Project, Institute of Mathematics, UiO (with Glad)
Supervison of post-docs:
2002, 2004 Dr. Med. Odd Terje Brustugun, NRH, Clinical fellowship at Dept. of Radiation Biology
Current supervision:
2008 Linn Cecilie Bergersen, Master degree, Institute of Mathematics, UiO (with Glad)
2008 Erlend Andersen, Master degree, Institute of Physics, UiO (with Malinen)
2008 Malin Lando, PhD, NRH
Academic duties
1993 - Referee work of more than 30 articles for 10 international journals.
1994 - Censor of projects (26) and diplomas/master (13) at NTNU and diploma (1) at the
Agricultural University of Norway
1996 - 2000 Censor of "Strålingsbiofysikk" for NTNU students
2006 Opponent for PhD student Live Eikenes, Institute of Physics, NTNU
Leadership and Management
1998 - 2000 Project leader within Group of Tumor Physiology and Radiation Biology
2001 - Project leader Project group of Clinical Radiation Biology
2001 - 2004 Represent the institution in Group of Translational Research, EORTC-RT, which was established in 2001 to increase the scientific outcome of radiotherapeutical studies in EORTC-RT
2001 - 2003 Responsible for arrangement of institute seminars together with a colleague
2002 - 2003 Member of user group at the institution for planning of new research building
2004 Coorganizer of PhD course in clinical radiation oncology, arranged by UiO and NRH
2007 - Engaged by SUFS (Senter for Forskning og Utdanning i Stråleterapi) to be responsible
for and promote translational radiation biology research on pelvic cancers at NRH
2008 Completed 1.5 years training course in Leadership, Stride AS and NRH
Awards
1990 Young Investigators Award, 38th Annual Meeting for Radiation Research Society
1991 Lund Science Award, best publication in International Journal of Hyperthermia
1991 Young Investigators Award, 9th International Conference for Radiation Research
1997 Young Investigators Award, 45th Annual Meeting for Radiation Research Society
1998 Junior Investigators Award, 10th International Conference on Chemical Modifiers of Cancer Treatment
2006 Nature Reviews Cancer Poster prize, 3rd International Conference on Translational Research and Pre-Clinical Strategies in Radiation Oncology
Society Memberships
American Association for Cancer Research (AACR)
Radiation Research Society (RRS)
European Society for Therapeutic Radiology and Oncology (ESTRO)
Publications
55 articles in international peer reviewed journals
7 book chapters
2 reports
Author network for Heidi Lyng by COREMINE medical
Publications 2012
Dynamic contrast-enhanced MRI of cervical cancers: temporal percentile screening of contrast enhancement identifies parameters for prediction of chemoradioresistance
Int J Radiat Oncol Biol Phys, 82 (3), e485-92
PubMed 22014954
Publications 2011
Pharmacokinetic analysis and k-means clustering of DCEMR images for radiotherapy outcome prediction of advanced cervical cancers
Acta Oncol, 50 (6), 859-65
PubMed 21767185
Weighted Lasso with Data Integration
Stat. Appl. Genet. Mol. Biol., 10 (1), 39
Phosphorylation of EGFR measured with in situ proximity ligation assay: relationship to EGFR protein level and gene dosage in cervical cancer
Radiother Oncol, 101 (1), 152-7
PubMed 21680035
Membranous expression of ectodomain isoforms of the epidermal growth factor receptor predicts outcome after chemoradiotherapy of lymph node-negative cervical cancer
Clin Cancer Res, 17 (16), 5501-12
PubMed 21737508
Three independent mechanisms for arrest in G2 after ionizing radiation
Cell Cycle, 10 (5), 819-29
PubMed 21325885
Publications 2009
Expression of 14-3-3sigma in cervical squamous cell carcinomas: relationship with clinical outcome
Oncol Rep, 22 (1), 11-5
PubMed 19513498
Gene dosage, expression, and ontology analysis identifies driver genes in the carcinogenesis and chemoradioresistance of cervical cancer
PLoS Genet, 5 (11), e1000719
PubMed 19911042
Publications 2008
Indirect genomic effects on survival from gene expression data
Genome Biol, 9 (3), R58
PubMed 18358079
Human papillomavirus DNA and e6/e7 mRNA status in relation to survival of patients treated for cervical squamous cell carcinoma
Open Virol J, 2, 74-81
PubMed 19440467
GeneCount: genome-wide calculation of absolute tumor DNA copy numbers from array comparative genomic hybridization data
Genome Biol, 9 (5), R86
PubMed 18500990
Validation of oligoarrays for quantitative exploration of the transcriptome
BMC Genomics, 9, 258
PubMed 18513391
Publications 2007
Metabolic mapping by use of high-resolution magic angle spinning 1H MR spectroscopy for assessment of apoptosis in cervical carcinomas
BMC Cancer, 7, 11
PubMed 17233882
Publications 2006
Gene expressions and copy numbers associated with metastatic phenotypes of uterine cervical cancer
BMC Genomics, 7, 268
PubMed 17054779
Publications 2005
Genome-wide estimation of transcript concentrations from spotted cDNA microarray data
Nucleic Acids Res, 33 (17), e143
PubMed 16204447
Response of malignant B lymphocytes to ionizing radiation: gene expression and genotype
Int J Cancer, 115 (6), 935-42
PubMed 15723354
The influence of missing value imputation on detection of differentially expressed genes from microarray data
Bioinformatics, 21 (23), 4272-9
PubMed 16216830
Publications 2004
The response of malignant B lymphocytes to ionizing radiation: cell cycle arrest, apoptosis and protection against the cytotoxic effects of the mitotic inhibitor nocodazole
Radiat Res, 162 (4), 405-15
PubMed 15447042
Profound influence of microarray scanner characteristics on gene expression ratios: analysis and procedure for correction
BMC Genomics, 5 (1), 10
PubMed 15018648
Intratumor chromosomal heterogeneity in advanced carcinomas of the uterine cervix
Int J Cancer, 111 (3), 358-66
PubMed 15221962
Publications 2001
Serial changes in tumor oxygenation during the early phase of radiation therapy in cervical cancer - Are we quantitating hypoxia change? Response
Int. J. Radiat. Oncol. Biol. Phys., 49 (1), 285-289
Intra- and intertumor heterogeneity in blood perfusion of human cervical cancer before treatment and after radiotherapy
Int J Cancer, 96 (3), 182-90
PubMed 11410887
Assessment of tumor oxygenation in human cervical carcinoma by use of dynamic Gd-DTPA-enhanced MR imaging
J Magn Reson Imaging, 14 (6), 750-6
PubMed 11747032
Microvessel oxyhemoglobin saturation does not reflect tissue oxygen tension in human melanoma xenografts
Microvasc Res, 61 (2), 199-202
PubMed 11254399
Publications 2000
Intratumor heterogeneity in perfusion in human melanoma xenografts measured by contrast-enhanced magnetic resonance imaging
Magn Reson Imaging, 18 (8), 997-1002
PubMed 11121704
Measurement of cell density and necrotic fraction in human melanoma xenografts by diffusion weighted magnetic resonance imaging
Magn Reson Med, 43 (6), 828-36
PubMed 10861877
Changes in tumor oxygen tension during radiotherapy of uterine cervical cancer: relationships to changes in vascular density, cell density, and frequency of mitosis and apoptosis
Int J Radiat Oncol Biol Phys, 46 (4), 935-46
PubMed 10705016
Disease control of uterine cervical cancer: relationships to tumor oxygen tension, vascular density, cell density, and frequency of mitosis and apoptosis measured before treatment and during radiotherapy
Clin Cancer Res, 6 (3), 1104-12
PubMed 10741740
Hypoxia-induced treatment failure in advanced squamous cell carcinoma of the uterine cervix is primarily due to hypoxia-induced radiation resistance rather than hypoxia-induced metastasis
Br J Cancer, 83 (3), 354-9
PubMed 10917551
Treatment outcome in advanced squamous cell carcinoma of the uterine cervix: relationships to pretreatment tumor oxygenation and vascularization
Radiother Oncol, 54 (2), 101-7
PubMed 10699471
Publications 1999
Changes in oxygen tension during radiotherapy of head and neck tumours
Acta Oncol, 38 (8), 1037-42
PubMed 10665759
Measurement of proliferation activity in human melanoma xenografts by magnetic resonance imaging
Magn Reson Imaging, 17 (3), 393-402
PubMed 10195582
Publications 1998
Measurement of perfusion rate in human melanoma xenografts by contrast-enhanced magnetic resonance imaging
Magn Reson Med, 40 (1), 89-98
PubMed 9660558
Oxygen tension and not vascular density or apoptosis predicts for metastasis in human cervix carcinoma
20TH EUROPEAN CONFERENCE ON MICROCIRCULATION, 13-17
Oxygen tension in human squamous cell carcinoma and adenocarcinoma of the uterine cervix
Adv Exp Med Biol, 454, 635-41
PubMed 9889944
Tumour hypoxia and vascular density as predictors of metastasis in squamous cell carcinoma of the uterine cervix
Br J Cancer, 78 (6), 822-7
PubMed 9743308
Oxygen tension and vascular density in adenocarcinoma and squamous cell carcinoma of the uterine cervix
Acta Oncol, 37 (7-8), 665-70
PubMed 10050984
Vascular density in human melanoma xenografts: relationship to angiogenesis, perfusion and necrosis
Cancer Lett, 123 (2), 159-65
PubMed 9489483
Publications 1997
Oxygen tension in human tumours measured with polarographic needle electrodes and its relationship to vascular density, necrosis and hypoxia
Radiother Oncol, 44 (2), 163-9
PubMed 9288845
Oxygen tension in primary tumours of the uterine cervix and lymph node metastases of the head and neck
Adv Exp Med Biol, 428, 55-60
PubMed 9500029
Proton relaxation times and interstitial fluid pressure in human melanoma xenografts
Br J Cancer, 75 (2), 180-3
PubMed 9010023
Polarographic measurement of pO2 in cervix carcinoma
Gynecol Oncol, 64 (2), 230-6
PubMed 9038268
Correlation of high lactate levels in head and neck tumors with incidence of metastasis
Am J Pathol, 150 (2), 409-15
PubMed 9033256
Publications 1996
Oxygen tension and vascular density in human cervix carcinoma
Br J Cancer, 74 (10), 1559-63
PubMed 8932335
Apoptosis, energy metabolism, and fraction of radiobiologically hypoxic cells: a study of human melanoma multicellular spheroids
Int J Radiat Biol, 70 (3), 241-9
PubMed 8800195
Hypoxia-induced tetraploidisation of a diploid human melanoma cell line in vitro
Br J Cancer Suppl, 27, S136-9
PubMed 8763866
Xenograft model systems for human melanoma
Mol Med Today, 2 (9), 394-403
PubMed 8885259
Interstitial fluid pressure, perfusion rate and oxygen tension in human melanoma xenografts
Br J Cancer Suppl, 27, S252-5
PubMed 8763891
Publications 1995
Detection of necrosis in human tumour xenografts by proton magnetic resonance imaging
Br J Cancer, 71 (3), 456-61
PubMed 7880724
MRI of human tumor xenografts in vivo: proton relaxation times and extracellular tumor volume
Magn Reson Imaging, 13 (5), 693-700
PubMed 8569443
31P NMR spectroscopy studies of phospholipid metabolism in human melanoma xenograft lines differing in rate of tumour cell proliferation
NMR Biomed, 8 (2), 65-71
PubMed 7547188
Treatment failure following sequential thermoradiotherapy of locally advanced breast carcinoma occurs primarily in poorly vascularized tumors
Oncology, 52 (6), 443-7
PubMed 7478428
Spin-lattice relaxation time of inorganic phosphate in human tumor xenografts measured in vivo by 31P-magnetic resonance spectroscopy. Influence of oxygen tension
Acta Oncol, 34 (3), 339-43
PubMed 7779420
Effect of melanin on phosphorus T1S in human melanoma xenografts studied by 31P MRS
Magn Reson Imaging, 13 (6), 847-52
PubMed 8544656
Publications 1994
31P-nuclear magnetic resonance spectroscopy in vivo of four human melanoma xenograft lines: spin-lattice relaxation times
Radiother Oncol, 32 (1), 54-62
PubMed 7938679
Non-invasive assessment of tumor oxygenation status by integrated 31P NMR spectroscopy and 1H NMR imaging
Adv Exp Med Biol, 345, 531-8
PubMed 8079755
Magnetic resonance imaging of human melanoma xenografts in vivo: proton spin-lattice and spin-spin relaxation times versus fractional tumour water content and fraction of necrotic tumour tissue
Int J Radiat Biol, 65 (3), 387-401
PubMed 7908318
Publications 1993
Prediction of treatment temperatures in clinical hyperthermia of locally advanced breast carcinoma: the use of contrast enhanced computed tomography
Int J Radiat Oncol Biol Phys, 26 (3), 451-7
PubMed 8390419
31P-nuclear magnetic resonance spectroscopy in vivo of six human melanoma xenograft lines: tumour bioenergetic status and blood supply
Br J Cancer, 68 (6), 1061-70
PubMed 8260356
Thermal dose and secondary tumour cell death
Int J Hyperthermia, 9 (5), 755-61
PubMed 8245585
Publications 1992
Blood flow in six human melanoma xenograft lines with different growth characteristics
Cancer Res, 52 (3), 584-92
PubMed 1732046
Publications 1991
The relevance of tumour and surrounding normal tissue vascular density in clinical hyperthermia of locally advanced breast carcinoma
Int J Radiat Biol, 60 (1-2), 189-93
PubMed 1677970
Temperature distribution in locally advanced breast carcinoma during hyperthermic treatment: relationship to perfusion, vascular density, and histology
Int J Radiat Oncol Biol Phys, 21 (2), 423-30
PubMed 1648045
Relationships between thermal dose and heat-induced tissue and vascular damage after thermoradiotherapy of locally advanced breast carcinoma
Int J Hyperthermia, 7 (3), 403-15
PubMed 1919137
Changes in temperatures and thermal doses with fraction number during hyperthermic treatment of locally advanced breast carcinoma
Int J Hyperthermia, 7 (6), 815-25
PubMed 1666900
Publications 1990
Positioning of temperature measurement points using multiplanar computed tomography
Int J Hyperthermia, 6 (5), 957-60
PubMed 2250121




Go back
Print this page
E-mail this page
